Effectiveness of Hyperthermia as Monotherapy and Adjuvant Therapy Approaches Against an In Vitro Model of Colorectal Carcinoma

• Published in: Anticancer research 2022-05, Vol.42 (5), p.2363-2374
• Main Authors: Petrakis, Georgios, Mantso, Theodora, Koukourakis, Michail I, Panayiotidis, Mihalis I, Botaitis, Sotiris
• Format: Article
• Language: English
• Subjects: 5-Fluorouracil; Adjuvant therapy; Apoptosis; Bevacizumab; Caco-2 Cells; Cancer; Cell cycle; Cell death; Cell viability; Colon; Colorectal cancer; Colorectal carcinoma; Colorectal Neoplasms - drug therapy; Colorectal Neoplasms - metabolism; Combined Modality Therapy; Cytotoxicity; Depolarization; Drugs; Fever; Flow cytometry; Humans; Hyperthermia; Hyperthermia, Induced; Membrane potential; Metastases; Mitochondria; Reactive oxygen species; Reactive Oxygen Species - metabolism; Survival; Therapy; Toxicity
• ISSN: 0250-7005; 1791-7530
• DOI: 10.21873/anticanres.15715

Despite improvement in current therapies, the 5-year overall survival rate of colorectal carcinoma is still low especially in its metastatic form. On the other hand, hyperthermia has been utilized as a cancer treatment approach to improve overall therapeutic efficacy. In the present study, we have aimed to develop an optimized hyperthermic protocol against an in vitro model of human colon carcinoma, as a single and/or adjuvant treatment approach. We have utilized an in vitro model of human colorectal carcinoma consisting of colorectal carcinoma (HT29, CaCo2) and normal colon epithelial (CCD841CoN) cell lines. Cells were exposed to 45°C, over 120 min, in the presence or absence of chemotherapeutic (5-Fluorouracil, Capecitabine) and targeted (Bevacizumab, Cetuximab) drugs. Cell viability levels were determined by the Alamar-blue assay while determination of cell death, reactive oxygen species (ROS) production, mitochondrial membrane depolarization (ΔΨμ) levels and cell cycle progression were performed by flow cytometry. CaCo2 and HT29 cells showed a differential response towards i) cell viability, ii) cell death, iii) ROS and ΔΨμ levels as well as iv) cell cycle distribution, in the presence of hyperthermia alone (monotherapy) or in combination with the above-mentioned drugs (adjuvant therapy). Finally, normal colon epithelial (CCD841CoN) cells remained minimally affected. We have developed an optimized experimental hyperthermic protocol, as a promising monotherapy and/or adjuvant therapy approach, with the capacity to potentiate chemotherapeutic as well as targeted drug-induced cytotoxicity against a model of colorectal carcinoma, to a variable degree.